Contineum Therapeutics Files 8-K on Security Holder Vote Matters
Ticker: CTNM · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1855175
| Field | Detail |
|---|---|
| Company | Contineum Therapeutics, Inc. (CTNM) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, filing
TL;DR
Contineum Therapeutics is holding a shareholder vote on June 26, 2025.
AI Summary
On June 26, 2025, Contineum Therapeutics, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, formerly known as Pipeline Therapeutics, Inc., is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing signals that Contineum Therapeutics is engaging its shareholders on important corporate decisions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine procedural update regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 001-42001 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-1467257 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Contineum Therapeutics, Inc. (company) — Registrant
- Pipeline Therapeutics, Inc. (company) — Former company name
- June 26, 2025 (date) — Date of report and earliest event
- Delaware (jurisdiction) — State of incorporation
- San Diego, California (location) — Principal executive offices
FAQ
What specific matters will be submitted to a vote of Contineum Therapeutics' security holders?
The filing states that matters are being submitted to a vote of security holders, but does not specify the exact nature of these matters in the provided text.
When was Contineum Therapeutics, Inc. formerly known as Pipeline Therapeutics, Inc.?
The date of the name change from Pipeline Therapeutics, Inc. to Contineum Therapeutics, Inc. was April 5, 2021.
Where are Contineum Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 3565 General Atomics Court, Suite 200, San Diego, California, 92121.
What is the standard industrial classification for Contineum Therapeutics, Inc.?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
What is the fiscal year end for Contineum Therapeutics, Inc.?
The fiscal year end for Contineum Therapeutics, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Contineum Therapeutics, Inc. (CTNM).